BIIB 241227 265.00P (BIIB241227P265000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BIIB241227P265000

Watchlist

0.00
0.000.00%

15min DelayTrading Dec 23 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Investors Aren't Entirely Convinced By Biogen Inc.'s (NASDAQ:BIIB) Earnings
Simply Wall StDec 23 10:16 ET
2024's Top and Bottom Nasdaq-100 Performers Includes NVDA, APP, INTC, MRNA, and More
Seeking AlphaDec 23 09:52 ET
Biogen Faces Multiple Analyst Downgrades in December 2024
Yahoo FinanceDec 23 05:07 ET
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Seeking AlphaDec 22 16:12 ET
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Seeking AlphaDec 22 10:12 ET
Leerink Partners Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $290
Moomoo NewsDec 20 13:43 ET · Ratings

Comments

Moomoo News Global

Dec 4 08:19

Columns Which Stocks Could Join the Nasdaq 100? Palantir and MicroStrategy Lead the List

The annual adjustment of the $NASDAQ 100 Index (.NDX.US)$ components will be announced next Friday (December 13). According to the market capitalization ranking, in addition to the strong performers $Palantir (PLTR.US)$ and $MicroStrategy (MSTR.US)$, $Equinix Inc (EQIX.US)$, and $Coinbase (COIN.US)$ are also expected to become new members.
On the other hand, six companies, headed by $Moderna (MRNA.US)$, $Super Micro Computer (SMCI.US)$, ...

Nasdaq hits 20k, with PLTR, MSTR, and AXON included in the NDX

J-Eazy

Nov 15 13:08

garabage

this stock is 🗑️
$Biogen (BIIB.US)$

QMengColdJoke

Nov 14 10:04

? you just saved world?

$Biogen (BIIB.US)$

Movers and Shakers

Oct 30 07:28

Columns Today's Pre-Market Movers and Top Ratings | GOOGL, AMD, V, LLY and More

Morning Movers
Gapping up
$Alphabet-A (GOOGL.US)$ stock rose 6.3% following third-quarter results that exceeded expectations, with a notable increase in advertising revenue, which alleviated concerns over competition from AI-driven search products.
$Biogen (BIIB.US)$ stock increased 1.2% after the biotech company raised its annual earnings forecast and reported third-quarter earnings that surpassed both top and bottom line expe...